← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORBION PHARMS · Approved 2017-12-11

Drug application

FDA Application #

ANDA202547

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

ORBION PHARMS

Manufacturer

Bionpharma Inc.

First approval

2017-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown